Literature DB >> 33897046

Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

William V Williams1,2,3, Joel Brind4, Laura Haynes5, Michael D Manhart6, Hanna Klaus3,7, Angela Lanfranchi3,4,8, Gerard Migeon9, Mike Gaskins10, Elvis I Seman11,12,13, Lester Ruppersberger3, Kathleen M Raviele3.   

Abstract

Hormonal contraceptives have been on the market for over fifty years and, while their formulations have changed, the basic mechanism of action has remained the same. During this time, numerous studies have been performed documenting side effects, some of which appear over time, some within weeks or months, but all can have a serious impact on health and quality of life. An effort was made to perform a series of comprehensive literature surveys to better understand immediate and long-term side effects of these agents. The results of this literature review uncovered a number of potential side effects, some of which are acknowledged and many of which are not noted in the prescribing information for these agents. Among the unacknowledged side effects are: an increased risk of HIV transmission for depot medroxyprogesterone acetate (DMPA), and for combination contraceptives breast cancer, cervical cancer, Crohn's disease, ulcerative colitis, systemic lupus erythematosus, depression, mood disorders and suicides (especially among women twenty-five years of age and younger, in the first six months of use), multiple sclerosis, interstitial cystitis, female sexual dysfunction, osteoporotic bone fractures (especially for progesterone-only contraceptives), and fatty weight gain. Misleading prescribing information regarding cardiovascular and thrombotic risks are also noted. Women seeking birth control have a right to be informed and educated about risk avoidance through the use of effective nonhormonal methods like fertility awareness methods. In one case-that of DMPA-the increased risk of HIV acquisition has been conclusively demonstrated to be both real and unique to this drug. Considering the availability of numerous alternatives, there is no justification for the continued marketing of DMPA to the public.
SUMMARY: We reviewed the effect of hormonal contraceptives on women's health. A number of potential side effects were noted including increased risks of breast cancer, cervical cancer, inflammatory bowel  disease, lupus, multiple sclerosis, cystitis, bone fractures, depression, mood disorders and suicides,  fatty weight gain, and female sexual dysfunction.  With the long-acting injectable contraceptives there is an increased risk of getting HIV.  Misleading prescribing information regarding the risks of heart attacks, strokes and blood clotting problems were also noted. Women seeking birth control have a right to know about how to avoid these risks by using effective hormone-free Fertility Awareness Methods. © Catholic Medical Association 2021.

Entities:  

Keywords:  Autoimmune disease; Cancer; Contraception; Fractures; Human immunodeficiency virus; Osteoporosis; Sexual dysfunction; Suicide; Thromboembolic disease; Weight gain

Year:  2021        PMID: 33897046      PMCID: PMC8033491          DOI: 10.1177/0024363920982709

Source DB:  PubMed          Journal:  Linacre Q        ISSN: 0024-3639


  101 in total

Review 1.  Modulation of HIV-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of HIV-1 pathogenesis.

Authors:  Janet Patricia Hapgood; Michele Tomasicchio
Journal:  Arch Virol       Date:  2010-05-06       Impact factor: 2.574

2.  Hormonal contraception and the development of autoimmunity: A review of the literature.

Authors:  William V Williams
Journal:  Linacre Q       Date:  2017-08-18

3.  Is the oral contraceptive pill associated with fracture in later life? New evidence from the Royal College of General Practitioners Oral Contraception Study.

Authors:  Sanam Memon; Lisa Iversen; Philip C Hannaford
Journal:  Contraception       Date:  2011-01-20       Impact factor: 3.375

4.  Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease.

Authors:  P G Godet; G R May; L R Sutherland
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

5.  Past use of oral contraceptives and the risk of developing systemic lupus erythematosus.

Authors:  J Sanchez-Guerrero; E W Karlson; M H Liang; D J Hunter; F E Speizer; G A Colditz
Journal:  Arthritis Rheum       Date:  1997-05

Review 6.  Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.

Authors:  Paul Appleby; Valerie Beral; Amy Berrington de González; Didier Colin; Silvia Franceschi; Adrian Goodhill; Jane Green; Julian Peto; Martyn Plummer; Siân Sweetland
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

7.  Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study.

Authors:  M Tuppurainen; R Honkanen; H Kröger; S Saarikoski; E Alhava
Journal:  Maturitas       Date:  1993-09       Impact factor: 4.342

Review 8.  Combination contraceptives: effects on weight.

Authors:  Maria F Gallo; Laureen M Lopez; David A Grimes; Florence Carayon; Kenneth F Schulz; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2014-01-29

9.  Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.

Authors:  Charles S Morrison; Pai-Lien Chen; Cynthia Kwok; Jared M Baeten; Joelle Brown; Angela M Crook; Lut Van Damme; Sinead Delany-Moretlwe; Suzanna C Francis; Barbara A Friedland; Richard J Hayes; Renee Heffron; Saidi Kapiga; Quarraisha Abdool Karim; Stephanie Karpoff; Rupert Kaul; R Scott McClelland; Sheena McCormack; Nuala McGrath; Landon Myer; Helen Rees; Ariane van der Straten; Deborah Watson-Jones; Janneke H H M van de Wijgert; Randy Stalter; Nicola Low
Journal:  PLoS Med       Date:  2015-01-22       Impact factor: 11.069

10.  Contemporary Hormonal Contraception and the Risk of Breast Cancer.

Authors:  Lina S Mørch; Charlotte W Skovlund; Philip C Hannaford; Lisa Iversen; Shona Fielding; Øjvind Lidegaard
Journal:  N Engl J Med       Date:  2017-12-07       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.